A study from the University of Washington Seattle studied the incidence of Graves’ disease before and after receiving the COVID-19 vaccine, determining no significant difference. Researchers also looked at levels of thyroid antibodies in the blood of patients with Graves’ hyperthyroidism before and after vaccination and found no significant difference.
Read More »An article published in Nature provides the most comprehensive compilation of research on long Covid to date, discussing what is currently known about its symptoms, prevalence, biomarkers, and disease mechanisms. Because long Covid does not have a single unifying mechanism, and has such broad multi-systemic symptoms, it likely has a broad range of causes and will likely be classified into separate illnesses in the future.
Read More »A recent study cited in Lupus Science and Medicine covered vaccine safety in patients with Systemic Lupus Erythematosus. 237 vaccinated SLE participants were included, and researchers found that rates of vaccine side effects reported by those with SLE were statistically similar to those in the general public; additionally, the majority of patients did not experience disease flare-ups in response to vaccination.
Read More »A study published in Neurology Neuroimmunology & Neuroinflammation examined the safety of COVID-19 vaccines in people with multiple sclerosis (MS). The COVER-MS study funded by the National MS Society used an online self-reporting database called iConquerMS to gather information from 719 adults with MS and record information on vaccine side effects. In addition, they were also able to compare the effects of vaccines from different manufacturers and various MS therapies.
Read More »